Dec. 03, 2025 /Mpelembe Media/ — This document announces the publication of a significant real-world evaluation concerning the effectiveness of an artificial intelligence platform used in acute stroke diagnosis. Brainomix, a medical imaging company, reported that its software, Brainomix 360 Stroke, was successfully studied over a five-year period using national data from over 450,000 patients admitted to NHS hospitals in England. The study found that using the AI platform was associated with a remarkable 100% increase in endovascular thrombectomy rates, which is a crucial procedure for treating severe strokes. Experts involved in the NHS collaboration affirmed that the technology significantly reduced delays in patient transfer and diagnosis, helping to increase treatment accessibility, especially in primary stroke centres lacking immediate specialist resources. Ultimately, the data supports the general use of AI imaging decision-support software in clinical guidelines due to its ability to improve patient outcomes. Continue reading